{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:35:38Z","timestamp":1768080938932,"version":"3.49.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001656","name":"helmholtz-gemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001656","name":"helmholtz-gemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001656","name":"helmholtz-gemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TH2231\/1-1"],"award-info":[{"award-number":["TH2231\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"publisher","award":["391217598"],"award-info":[{"award-number":["391217598"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"publisher","award":["391217598"],"award-info":[{"award-number":["391217598"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"publisher","award":["369799452"],"award-info":[{"award-number":["369799452"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"deutsche forschungsgemeinschaft","doi-asserted-by":"publisher","award":["369799452"],"award-info":[{"award-number":["369799452"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008426","name":"friedrich-baur-stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008426","id-type":"DOI","asserted-by":"publisher"}]},{"name":"center for integrated protein science, munich"},{"DOI":"10.13039\/501100008848","name":"elitenetzwerk bayern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008848","name":"elitenetzwerk bayern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008848","name":"elitenetzwerk bayern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008848","name":"elitenetzwerk bayern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>There is an urgent need for better diagnostic and analytical methods for vaccine research and infection control in virology. This has been highlighted by recently emerging viral epidemics and pandemics (Zika, SARS-CoV-2), and recurring viral outbreaks like the yellow fever outbreaks in Angola and the Democratic Republic of Congo (2016) and in Brazil (2016\u20132018). Current assays to determine neutralising activity against viral infections in sera are costly in time and equipment and suffer from high variability. Therefore, both basic infection research and diagnostic population screenings would benefit from improved methods to determine virus-neutralising activity in patient samples. Here we describe a robust, objective, and scalable <jats:bold>Fluo<\/jats:bold>rescence <jats:bold>R<\/jats:bold>eduction <jats:bold>N<\/jats:bold>eutralisation <jats:bold>T<\/jats:bold>est (FluoRNT) for yellow fever virus, relying on flow cytometric detection of cells infected with a fluorescent Venus reporter containing variant of the yellow fever vaccine strain 17D (YF-17D-Venus). It accurately measures neutralising antibody titres in human serum samples within as little as 24 h. Samples from 32 vaccinees immunised with YF-17D were tested for neutralising activity by both a conventional focus reduction neutralisation test (FRNT) and FluoRNT. Both types of tests proved to be equally reliable for the detection of neutralising activity, however, FluoRNT is significantly more precise and reproducible with a greater dynamic range than conventional FRNT. The FluoRNT assay protocol is substantially faster, easier to control, and cheaper in per-assay costs. FluoRNT additionally reduces handling time minimising exposure of personnel to patient samples. FluoRNT thus brings a range of desirable features that can accelerate and standardise the measurement of neutralising anti-yellow fever virus antibodies. It could be used in applications ranging from vaccine testing to large cohort studies in systems virology and vaccinology. We also anticipate the potential to translate the methodology and analysis of FluoRNT to other flaviviruses such as West Nile, Dengue and Zika or to RNA viruses more generally.<\/jats:p>","DOI":"10.1371\/journal.pone.0262149","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T18:34:38Z","timestamp":1644431678000},"page":"e0262149","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D"],"prefix":"10.1371","volume":"17","author":[{"given":"Magdalena K.","family":"Scheck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-3371","authenticated-orcid":true,"given":"Lisa","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-1525","authenticated-orcid":true,"given":"Magdalena","family":"Zaucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Schwarzlmueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7383-8750","authenticated-orcid":true,"given":"Michael","family":"Pritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Barba-Spaeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Thorn-Seshold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne B.","family":"Krug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Endres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1151-7614","authenticated-orcid":true,"given":"Simon","family":"Rothenfusser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4879-4159","authenticated-orcid":true,"given":"Julia","family":"Thorn-Seshold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"pone.0262149.ref001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41590-017-0007-9","article-title":"Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic","volume":"19","author":"BS Graham","year":"2018","journal-title":"Nat Immunol"},{"key":"pone.0262149.ref002","doi-asserted-by":"crossref","first-page":"182","DOI":"10.12688\/wellcomeopenres.15579.1","article-title":"YEFE and NIFTY vaccine trials teams. Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda","volume":"4","author":"D Kimathi","year":"2019","journal-title":"Wellcome Open Res"},{"key":"pone.0262149.ref003","article-title":"Vaccines and vaccination against yellow fever","author":"World Health Organization Geneva","year":"2013","journal-title":"WHO Position Pap\u2014June 2013. Wkly Epidemiol Rec"},{"key":"pone.0262149.ref004","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1098\/rstb.2011.0354","article-title":"Human viruses: discovery and emergence","volume":"367","author":"M Woolhouse","year":"2012","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"pone.0262149.ref005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"M Theiler","year":"1937","journal-title":"J Exp Med"},{"key":"pone.0262149.ref006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-017-0566-9","article-title":"Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day.","volume":"19","author":"ND Collins","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"pone.0262149.ref007","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"B. Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"pone.0262149.ref008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"TD Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"pone.0262149.ref009","first-page":"539","article-title":"Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine","volume":"25","author":"RA Mason","year":"1973"},{"key":"pone.0262149.ref010","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial","volume":"3","author":"AH Roukens","year":"2008","journal-title":"PLoS ONE"},{"key":"pone.0262149.ref011","first-page":"9","article-title":"Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination","author":"JE Huber","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"pone.0262149.ref012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika\u2013dengue virus antibody cross-neutralization","volume":"536","author":"G Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"pone.0262149.ref013","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"G Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"key":"pone.0262149.ref014","first-page":"11","article-title":"A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.","author":"RW Wieten","year":"2016","journal-title":"PLoS ONE"},{"key":"pone.0262149.ref015","doi-asserted-by":"crossref","first-page":"taab126","DOI":"10.1093\/jtm\/taab126","article-title":"Long-term immunity after a single yellow fever vaccination in travelers vaccinated at 60 years or older: A 10-year follow-up study","author":"MD Rosenstein","year":"2021","journal-title":"J Travel Med"},{"key":"pone.0262149.ref016","doi-asserted-by":"crossref","first-page":"e0177882","DOI":"10.1371\/journal.pone.0177882","article-title":"Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype","volume":"12","author":"S Mercier-Delarue","year":"2017","journal-title":"PLOS ONE"},{"key":"pone.0262149.ref017","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4269\/ajtmh.17-0948","article-title":"Virus Reduction Neutralization Test: A Single-Cell Imaging High-Throughput Virus Neutralization Assay for Dengue","volume":"99","author":"MC Whiteman","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0262149.ref018","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CVI.00209-16","article-title":"Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay","volume":"23","author":"F Adungo","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"pone.0262149.ref019","doi-asserted-by":"crossref","first-page":"e1001255","DOI":"10.1371\/journal.ppat.1001255","article-title":"Identification and Characterization of the Host Protein DNAJC14 as a Broadly Active Flavivirus Replication Modulator","volume":"7","author":"Z Yi","year":"2011","journal-title":"PLoS Pathog"},{"key":"pone.0262149.ref020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4939-0348-1_4","volume-title":"Dengue","author":"JL Tan","year":"2014"},{"key":"pone.0262149.ref021","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis.","volume":"9","author":"J Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"pone.0262149.ref022","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection","volume":"56","author":"B Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"pone.0262149.ref023","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"JE Staples","year":"2010","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"key":"pone.0262149.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-020-0101-0","article-title":"Yellow fever control: current epidemiology and vaccination strategies","volume":"6","author":"LH Chen","year":"2020","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"pone.0262149.ref025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years","volume":"89","author":"E Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0262149.ref026","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMoa1710430","article-title":"Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak\u2014Final Report","volume":"381","author":"RM Casey","year":"2019","journal-title":"N Engl J Med"},{"key":"pone.0262149.ref027","first-page":"113","article-title":"Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation","author":"C Possas","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pone.0262149.ref028","doi-asserted-by":"crossref","first-page":"e41707","DOI":"10.1371\/journal.pone.0041707","article-title":"A Flow Cytometry-Based Assay for Quantifying Non-Plaque Forming Strains of Yellow Fever Virus","volume":"7","author":"E Hammarlund","year":"2012","journal-title":"PLoS ONE"},{"key":"pone.0262149.ref029","doi-asserted-by":"crossref","first-page":"16624","DOI":"10.1038\/s41598-018-34865-y","article-title":"High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon","volume":"8","author":"M Matsuda","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0262149.ref030","first-page":"56","article-title":"Ability To Serologically Confirm Recent Zika Virus Infection in Areas with Varying Past Incidence of Dengue Virus Infection in the United States and U.S. Territories in 2016.","author":"NP Lindsey","year":"2018","journal-title":"J Clin Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0262149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T18:35:15Z","timestamp":1644431715000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0262149"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Roques","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0262149","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]}}}